Patient-reported outcomes of migraine treatment with erenumab versus topiramate: Results from the HER-MES study

Authors
Category Primary study
ConferenceHeadache
Year 2022
This article has no abstract
Epistemonikos ID: 1e10d36e9cb627d7a4637a697a582842af8bca64
First added on: Apr 30, 2026